Future EU MRL amendments: publication expected early 2023

22 Nov 2022

In September 2022, the EU SCoPAFF (Standing Committee on Plants, Animals, Food and Feed) agreed to changes to EU MRLs for a number of active substances under Regulation (EC) No 396/2005.

If these pass scrutiny by the European Parliament and Council, we can expect the publication of EU implementing Regulations for the revised MRLs in the next 4-6 months. The MRLs are likely to come into force 6 months following publication i.e. by mid-2023.

It is expected that EU MRLs will be amended for the following active substances:

• cycloxydim
• cyflumetofen
• cyfluthrin
• metobromuron
• penthiopyrad and 1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide
• abamectin
• clothianidin
• thiamethoxam
• cyromazine
• topramezone
• triflumizole
• benalaxyl
• bromoxynil
• chlorsulfuron
• fenamiphos
• epoxiconazole
• benzalkonium chloride (BAC)
• chlorpropham
• didecyldimethylammonium chloride (DDAC)
• flutriafol
• metazachlor
• nicotine
• profenofos
• quizalofop-P
• sodium aluminium silicate
• thiabendazole
• triadimenol

Find out which commodities are affected by searching for the active substance in the EU MRL database. Related changes proposed to EU MRLs will shortly appear in the 'not yet applicable' column.

The list above does not include EU MRLs resulting from applications to raise EU MRLs, e.g. to support new PPP uses, or proposals to list active substances on Annex IV of Regulation (EC) No 396/2005 (actives not subject to MRLs).